Surgical Waste Intervertebral Disc Tissue Analysis

Overview

About this study

The overall aim of this project is to study the interaction between white blood cells (inflammation) and disc degeneration.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Patients undergoing elective spine surgery for:
    • Degenerative disc disease
    • Adults with scoliosis

Exclusion Criteria:

  • Patients who have previously received immune-suppressive therapies not including NSAIDs and acetaminophen.
  • Vulnerable patient populations (e.g., pregnant women, children, adults lacking capacity to consent, prisoners, non-native English speakers.
  • Recent infection (<1 month), including the common cold
  • History of cancer
  • Autoimmune diseases

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Wenchun Qu, M.D., M.S., Ph.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20307904

Mayo Clinic Footer